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Impact of Socioeconomic Differences on
Distributional Cost-effectiveness Analysis
Fan Yang , Colin Angus, Ana Duarte , Duncan Gillespie,
Simon Walker, and Susan Griffin
Public health decision makers value interventions for their effects on overall health and health inequality.
Distributional cost-effectiveness analysis (DCEA) incorporates health inequality concerns into economic evaluation
by accounting for how parameters, such as effectiveness, differ across population groups. A good understanding of
how and when accounting for socioeconomic differences between groups affects the assessment of intervention
impacts on overall health and health inequality could inform decision makers where DCEA would add most value.
We interrogated 2 DCEA models of smoking and alcohol policies using first national level and then local authority
level information on various socioeconomic differences in health and intervention use. Through a series of scenario
analyses, we explored the impact of altering these differences on the DCEA results. When all available evidence on
socioeconomic differences was incorporated, provision of a smoking cessation service was estimated to increase over-
all health and increase health inequality, while the screening and brief intervention for alcohol misuse was estimated
to increase overall health and reduce inequality. Ignoring all or some socioeconomic differences resulted in minimal
change to the estimated impact on overall health in both models; however, there were larger effects on the estimated
impact on health inequality. Across the models, there were no clear patterns in how the extent and direction of socio-
economic differences in the inputs translated into the estimated impact on health inequality. Modifying use or cover-
age of either intervention so that each population group matched the highest level improved the impacts to a greater
degree than modifying intervention effectiveness. When local level socioeconomic differences were considered, the
magnitude of the impacts was altered; in some cases, the direction of impact on inequality was also altered.
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Cost-effectiveness analysis (CEA) is routinely employed
to inform health care resource allocation decisions.1
When allocating resources in public health, decision
makers often consider how potential policies would
improve population health and reduce unfair health
inequalities (i.e., reduce the perceived unfairness of the
distribution of health across the population).2,3 The deci-
sion about whether to fund a public health intervention
is therefore informed by its impact on the distribution of
health across the population, both in terms of its sum
total and the extent of inequality between relevant popu-
lation groups. The distributional cost-effectiveness analy-
sis (DCEA) framework considers how interventions
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affect the distribution of health.4,5 It is used to estimate
the net impact of an intervention on overall health and
in each population group of interest and to examine the
trade-offs between improving overall health and reduc-
ing health inequality.
To perform DCEA, the evaluation of costs and conse-
quences of alternative interventions must account for dif-
ferences between equity relevant groups.6 This requires
evidence on how the parameters of the evaluation (e.g.,
the value of inputs to a decision analytic model) vary
between groups. Lack of evidence on between-group dif-
ferences can make it challenging to conduct a formal eva-
luation. Even when the evidence is available, a DCEA is
more complex than a standard CEA, and policy makers
may lack the resources to undertake DCEA in all circum-
stances. Developing greater understanding of how and
when accounting for socioeconomic differences in model
inputs affects the final estimate of the intervention impact
on the distribution of health could enable us to identify a
subset of parameters that are sufficient to inform the
intervention impact, which may make it possible to sim-
plify the DCEA process and help decision makers and
analysts to know where DCEA would add most and when
to gather further evidence on socioeconomic differences.
When appraising how an intervention affects health
inequality, a common question is whether anything can
be done to modify either the intervention itself or the
way in which it is delivered to make it benefit population
groups more fairly.7 For example, if uptake of the inter-
vention is socially patterned, policy makers may ask
whether it is worthwhile to invest in actions that increase
uptake in lower socioeconomic groups. A breakdown
showing how eliminating socioeconomic differences in
each model input could alter the final distribution of
health could help direct efforts to answer such questions.
In the United Kingdom, local authorities have the
responsibility of making decisions about which public
health interventions to fund for their local population.
However, many appraisals of the potential interventions
are performed and reported at a national level.8 The extent
of socioeconomic differences in model inputs can vary
between settings (e.g., the smoking prevalence by socioeco-
nomic status within local authorities differs from the over-
all national figure).9 The population distribution between
socioeconomic groups may also differ between settings.
Consequently, evaluating the intervention impact based on
national level estimates may not be informative for the
impact that would be expected at a local level. Therefore,
it may be relevant to local decision makers to understand
how local level variation will alter estimated policy impacts
compared with the national level estimates.
In this study, we adapted 2 existing DCEA models of
public health interventions to address 4 broad questions:
1. How influential is failing to consider specific socioe-
conomic differences on the estimated intervention
impacts on overall health and health inequality?
2. Which modifiable intervention characteristics repre-
sent the most valuable targets to mitigate socioeco-
nomic differences in intervention impact?
3. How generalizable are conclusions about the inter-
vention impacts on overall health and health inequal-
ity between areas with different characteristics?
4. What conclusions can we draw about the generaliz-
ability of the results of the 2 studies to other inter-
ventions or disease areas?
Methods
Overview
DCEA of smoking and alcohol policies were conducted
using 2 existing models.10,11 Health benefits were expressed
as quality-adjusted life-years (QALYs) and costs in pounds
sterling (£, 2018 price year) under a National Health
Service (NHS) and personal social services perspective. An
annual discount rate of 3.5% was applied to both benefits
and costs in accordance with National Institute for Health
and Care Excellence (NICE) guidance.12 The NICE cost-
effectiveness threshold of £20,000 per QALY was used.13
In both models, we considered inequality between pop-
ulation groups defined according to the level of socioeco-
nomic deprivation in individuals’ area of residence (i.e.,
Index of Multiple Deprivation [IMD]).14 IMD is an area-
level weighted composite index combining information on
income, employment, health, education, housing, crime,
and living environment for a geographical area of approx-
imately 1500 residents.14 As IMD is not an individual-
level measure, there will be variation in the socioeconomic
status of residents within each area, and even highly
deprived areas will have some high socioeconomic status
inhabitants. The population was divided into 5 groups
defined by quintile of IMD, and differences in model
inputs across IMD quintiles were characterized. Both
models estimate the amount by which policies change
health within each population group. Summing over the
change in health across all 5 groups gives the total change
in population health, expressed as population incremental
net health benefit (NHB).1
Considering the general population’s preference for
reducing health inequality between rich and poor groups,
we can present the total population health as the equally
distributed equivalent (EDE) health. To calculate this
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EDE health, the strength of preference for reducing
inequality is used as a weight to provide a weighted total
population health. EDE health can be interpreted as the
amount of health distributed equally to all population
groups that would be considered equally valuable to the
distribution being evaluated.4 Given the preference for
reducing existing health inequalities, the EDE is lower
than the population health, and the difference describes
the amount of overall health that people would be
willing to sacrifice to achieve an equal distribution.
Alternatively, the difference between the EDE and the
total population health can be interpreted as the welfare
cost of health inequality, as it represents the social
value that could be gained if health were redistributed
equally. A policy that leaves the total population health
unchanged but reduces the difference in health between
population groups will increase the EDE health. We
expressed the policy impact on health inequality using
the difference between how policies alter the EDE health
(which increases with total health improvement and with
reduction of inequality in health) and how policies alter
total health (incremental NHB).
Scenario analyses were performed to explore how
altering socioeconomic differences in model inputs affects
the estimated impacts.
Models
The smoking model is a cohort Markov model that
assesses the cost-effectiveness of nicotine replacement
therapies in adult smokers (18–75 years) over a lifetime
horizon.10 These therapies are accessed through primary
care.10 The Markov model includes 3 mutually exclusive
health states: smokers, former smokers, and death.
Smokers and former smokers differ in mortality risk,
health-related quality of life (HRQoL), and risk of devel-
oping 6 smoking-related diseases, modeled as events with
an impact on costs and HRQoL. The Sheffield Alcohol
Policy Model is a hybrid simulation consisting of 2 linked
models that evaluates the cost-effectiveness of screening
and brief interventions (SBIs) to reduce alcohol misuse.11
The first part of the model takes a baseline population of
individual drinkers and simulates receipt of SBIs and the
resulting age-adjusted trends in alcohol consumption
over a 20-year time horizon. The second part of the
model aggregates these individuals into cohorts based on
age, gender, IMD quintile, and baseline drinking level.
The model simulates 45 alcohol-related health condi-
tions, which are linked to associated mortality rates and
hospital admissions.
In this study, we focus on the provision of e-cigarette
in the smoking model and the strategy of delivering SBIs
to all patients when registering with a new primary care
practice (‘‘Next Registration’’) in the alcohol model, both
compared with ‘‘no intervention.’’
Impact on Overall Health
The models estimate the incremental direct health benefits
and incremental health care costs of the interventions,
compared with no intervention, specific to smokers and
alcohol users in each IMD quintile. Zero health benefit
accrues to people who are not eligible for the interven-
tions (i.e., non-smokers and those who do not misuse
alcohol). The incremental costs are converted into health
opportunity costs (i.e., the health that would have been
achieved if those resources had been used for other pur-
poses) using the NICE cost-effectiveness threshold. The
health benefits of making resources available for other
purposes will not fall equally to all socioeconomic groups.
Research has shown that a greater proportion of the ben-
efit from changes in NHS spending goes to more deprived
groups. Deprived groups therefore lose out most when
resources are appropriated for specific policies or conver-
sely stand to gain the most when policies are cost saving
and release resources.15 For each IMD quintile, the health
opportunity costs are subtracted from the direct health
benefits to provide the distribution of the incremental net
health benefit (iNHB; i.e., the change in health by popu-
lation group). The impact on overall health is the popula-
tion iNHB (i.e., the sum of iNHB across all quintiles).
Impact on Health Inequality
The baseline distribution of health is the distribution of
quality-adjusted life expectancy (QALE),16 which com-
bines differences in life expectancy between groups with
differences in quality of life between groups. The iNHB
in each IMD quintile estimated for each intervention is
added to the baseline QALE in each IMD quintile to
estimate the predicted distribution of QALE following
the implementation of the intervention. The QALE dis-
tribution is summarized as EDE health by using the
Atkinson index, with an inequality aversion parameter
derived from a UK population survey.17 The Atkinson
inequality aversion parameter describes the strength of
preference for reducing relative inequality in health.
When applied to calculate the EDE, it assigns a higher
weight to health improvements in more deprived groups
that have lower baseline QALE and a lower weight to
health improvements in less deprived groups with greater
baseline QALE.18 The change from the EDE in the base-
line health to the EDE of the health with the intervention
(i.e., incremental EDE; iEDE) encompasses the impact
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of the intervention on both overall health and health
inequality. To isolate the impact on health inequality, we
look at the difference between iEDE and iNHB, with a
positive value showing that the intervention reduces
health inequality. We illustrate these calculations for the
smoking model in Box 1.
Box 1 Smoking Cessation Model
1. Extract the incremental direct health benefits (a) and the incremental health care costs (b) of e-cigarette versus ‘‘no
intervention’’ from the smoking DCEA model for each IMD quintile in England.
2. Sum the incremental costs (c) and then convert to health opportunity costs at a rate of £20,000 per QALY (d),
i.e., £ (2156,391,946)/£20,000 = 27820 QALYs.
3. Use the proportion of the health opportunity costs borne by each IMD quintile (e) to calculate the size of the health
opportunity costs in each IMD quintile (f), e.g., health opportunity costs for IMD1 is 27820 3 0.26 = 22033 QALYs.
4. Calculate the incremental NHB for each IMD quintile (g) by subtracting health opportunity costs from the incremental
direct health benefits, e.g., the incremental NHB for IMD1 is 6560 2 (22033) = 8593 QALYs.
5. Calculate the incremental NHB per capita by IMD quintile (i) using the distribution of the adult population of England
(h), e.g., IMD1, the individual incremental NHB, is 8593/8,307,456 = 0.0010 QALYs.
6. Add the individual incremental NHB to the baseline QALE (j) to calculate the QALE with the intervention by IMD quintile (k).
7. Calculate EDE for the baseline QALE distribution (l) and the QALE distribution with the intervention (m) using the










hi = individual QALE for a person in IMD quintile i
N = total population size
e = Atkinson inequality aversion parameter
8. Calculate the population incremental EDE with the intervention (n), i.e., the difference of population EDE with the
intervention and the population baseline EDE, where the population EDE is multiplying EDE by total population size.
9. Calculate the population incremental NHB with the intervention (o), i.e., sum the incremental NHB across all quintiles.
10. Calculate how the intervention changes health inequality (iEDE 2 iNHB) (p), i.e., 70,002 2 80,782 = 210,780 QALYs.
IMD1
(Most Deprived) IMD2 IMD3 IMD4
IMD5
(Least Deprived)
1. (a) Incremental direct health benefits,a QALYs 6560 15,619 13,201 19,350 18,233
(b) Incremental costs,a£ 212,544,948 232,507,825 229,016,052 242,924,171 239,398,949
2. (c) Total incremental costs (sum of b), £ 2156,391,946
(d) Total health opportunity costs (c/20,000),
QALYs
27820
3. (e) Proportion of health opportunity costsb 0.26 0.22 0.22 0.16 0.14
(f) Health opportunity costs (d 3 e), QALYs 22033 21720 21720 21251 21095
4. (g) Incremental NHB (a–f), QALYs 8593 17,339 14,921 20,601 19,328
5. (h) Population sizec 8,307,456 8,863,275 8,790,681 8,657,257 8,376,275
(i) Individual iNHB (g/h), QALYs 0.0010 0.0020 0.0017 0.0024 0.0023
6. (j) Baseline QALE (no intervention)d 64.7 68.5 70.6 73.6 75.6
(k) QALE with e-cigarette (i + j) 64.7010 68.5020 70.6017 73.6024 75.6023
7. (l) Baseline EDE, QALYs 69.465
8. (m) EDE with the intervention, QALYs 69.467
(n) Population iEDE
(m 3 sum of h – l 3 sum of h), QALYs
70,002
9. (o) Impact on overall health (sum of g) 80,782
10. (p) Impact on health inequality (n 2 o) 210,780
DCEA, distributional cost-effectiveness analysis; EDE, equally distributed equivalent; iEDE, incremental equally distributed equivalent; IMD,
Index of Multiple Deprivation; iNHB, incremental net health benefit; NHB, net health benefit; QALY, quality-adjusted life-years; QALE,
quality-adjusted life expectancy.
aCalculated using results from the model.
bLove-Koh et al. Estimating social variation in the health effects of changes in healthcare expenditure. Medical Decision Making. 2020.
cOffice for National Statistics (ONS) mid-year population estimates 2017.
dLove-Koh et al. The social distribution of health: estimating quality-adjusted life expectancy in England. Value Health. 2015.
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Inequality in Model Inputs
Model inputs in which we reflect socioeconomic differ-
ences were categorized into 4 groups: background
parameters, behaviors, health consequences of beha-
vior, and intervention characteristics. The level and
direction of inequality in these model inputs between
population groups are summarized using the concen-
tration index19 (Table 1). It ranges from 21 to 1, with
negative values demonstrating higher values of the
input in more deprived groups, whereas positive values
demonstrate higher values in less deprived groups. The
following sections give an overview of each category of
input, and more detailed information is available in the
Supplementary Appendix.
Background Parameters
Background parameters reflect the level of health that
would be observed without interventions, including the
baseline QALE16 and health opportunity costs.15
Baseline QALE is higher in less deprived areas, and more
health opportunity costs fall on residents in more
deprived areas (Table 1).
Behaviors
Behaviors including smoking prevalence and abstention
from drinking by IMD quintile were based on survey
data. The smoking model incorporated the proportion of
smokers in each IMD quintile.9 The alcohol model incor-
porated socioeconomic differences in abstention from
drinking, average weekly consumption, and peak day
drinking. People in more deprived groups were more
likely to smoke but less likely to drink, drink less on aver-
age, and binge drink at lower levels (Table 1).
Health Consequences of Behavior
Health consequences of behavior include mortality,
related diseases, and HRQoL. In the smoking model, the
annual mortality rates for smokers (Supplementary
Figure S1) were based on general population all-cause
mortality20; proportion of smokers, former smokers, and
nonsmokers21; and the increased relative risk of death for
smokers.22 Mortality in the alcohol model was modeled
separately by health condition, including alcohol-related
mortality and all other causes combined (Supplementary
Figure S2). In both models, there was a higher death rate
in more deprived areas (Table 1).
The socioeconomic difference in the smoking-related
diseases was estimated using the average population inci-
dence21 and the relative risk between IMD quintiles of
developing smoking-related disease.23 We assumed that
the middle IMD quintile (i.e., IMD3) was represented by
the average incidence of smoking-related disease and
then applied relative risks to estimate the incidence in
other IMD quintiles. Data on alcohol-related diseases
were obtained from individual hospital records. People
living in more deprived areas were more likely to develop
smoking- and alcohol-related diseases (Table 1).
The smoking model included HRQoL for smokers
and former smokers by IMD quintile, estimated from
survey data by linear regression (details available in
Supplementary Table S6). People living in less deprived
areas tended to have higher HRQoL (Table 1). The same
decrement in HRQoL for each smoking-related disease
Table 1 Category and Concentration Index of Model Inputs Incorporating Socioeconomic Difference
Category Socioeconomic difference in: Concentration Index
Background parameters (both models) Baseline quality-adjusted life expectancy 0.03
Health opportunity costs 20.12
Behaviors Smoking: prevalence 20.08
Alcohol: abstention from drinking 0.06
Alcohol: average weekly consumption 0.03
Alcohol: peak day consumption 0.06




Smoking: health-related quality of life 0.01
Intervention characteristics Smoking: intervention effectiveness (quit smoking) 0.04
Smoking: intervention uptake 0.17
Alcohol: individuals screened for alcohol misuse 20.01
Alcohol: probability of screening positive 20.01
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was applied across all IMD quintiles, as no evidence was
identified to inform differential effects. In the alcohol
model, separate HRQoL values were applied for each
alcohol-related health condition for each age-sex sub-
group,24 with no evidence available for differences by
IMD quintile.
In both models, the health care costs associated with
disease-related events were not differentiated by IMD, as
we did not identify evidence that would let us impose a
different health care costs per health event by deprivation.
Intervention Characteristics
Socioeconomic differences in intervention impact were
incorporated in both models. In the smoking model, the
socioeconomic difference in effectiveness (Supplementary
Table S7) was incorporated assuming that the middle
quintile was represented by the average quit rate for the
intervention25 and then applying the relative risk of
quitting between IMD quintiles.26 The socioeconomic
difference in intervention uptake was based on the pro-
portion of smokers supplied with an NHS Stop Smoking
Service.21 In the alcohol model, we did not consider
socioeconomic difference in the intervention effect because
of the lack of clear evidence but incorporated the difference
in the access to the intervention. This consists of an initial
step in which individuals attending primary care were
selected to be screened, informed by the rates at which indi-
viduals register with new general practitioner practices,27
(Supplementary Table S8) and a second step in which those
identified as drinking at potentially risky levels (screen pos-
itive) receive an intervention, estimated using the Alcohol
Toolkit Study28 (Supplementary Table S9). The concentra-
tion indices show higher effectiveness and uptake of smok-
ing cessation in less deprived areas, whereas those for
alcohol interventions show higher screening coverage and
screening positive in more deprived areas (Table 1).
Local Authority Level Inputs
To contrast national level results to local area results, we
selected two local authorities with distinct socioeconomic
profiles (smoking: York and Sheffield; alcohol: Liverpool
and Trafford). More residents in York and Trafford lived
in the least deprived quintile as compared with England as
a whole, while in Sheffield and Liverpool, more residents
were living in the most deprived quintile (Supplementary
Figures S3 and S4).29 The smoking model used local infor-
mation on smoking prevalence only (Supplementary Figure
S5), while the alcohol model included local information on
mortality and morbidity rates from alcohol-related diseases,
the abstention of drinking, and mean weekly alcohol con-
sumption (Supplementary Figure S6). The remaining differ-
ences for other parameters were based on national level
figures in the absence of relevant data.
Analysis
A series of scenario analyses was performed to explore
the impact of altering the socioeconomic differences in
model inputs on DCEA results, corresponding to the
4 questions raised in introduction. The intervention
impacts estimated in each scenario analysis were com-
pared with the base case estimates, which constitute the
results when all of the socioeconomic differences in the
model inputs mentioned previously are incorporated. We
assume that the base case represents the best estimate of
the intervention impacts. The base case results and the
results of each scenario analysis are presented as scatter
plots on the health equity impact plane.3 The differences
from the base case reflect in which direction and to what
extent each scenario affects how well each model esti-
mates the intervention impact on the distribution of
health.
Question (a): all model inputs were set to the popula-
tion average value in all IMD quintiles. This is equivalent
to a standard CEA in which only the average population
impact on overall health is calculated. It was expected
that ignoring all socioeconomic differences would have
minimal effect on the estimated impact on overall health
but a larger effect on the impact on health inequality. We
then excluded socioeconomic difference in one model
input at a time and compared the model outputs with the
base case estimates. This illustrates to what degree ignor-
ing socioeconomic difference in each model input would
affect the estimates of impacts on overall health and
health inequality.
Question (b): the model inputs we identified as poten-
tially modifiable intervention characteristics were set to
the highest level achieved in any of the groups to explore
the value of ‘‘leveling up’’ to eliminate the differences. In
the smoking model, all groups were assumed to have the
highest probability of quitting smoking and highest inter-
vention uptake rate. In the alcohol model, the alcohol
misuse screening coverage was assumed to go up to the
highest level across all quintiles within the same age-sex
group (‘‘age-sex max’’) and also the highest across all
age-sex-deprivation groups (‘‘global max’’).
Question (c): the model inputs reflecting socioeco-
nomic differences at the local level were incorporated to
estimate the base case results for 2 local authorities in
each model. To enable comparisons across areas that
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differ in population size, the intervention impacts for
100,000 adults were presented. The base case results at
the local level were compared between local authorities
and to the results for the nation as a whole.
Question (d): as the 2 models evaluated different inter-
ventions in different disease areas, we compared the
results of the above-mentioned analyses in the 2 models
to assess how the conclusions might vary between mod-
els. In addition, for analyses in addressing question (a),
we rearranged the results by plotting the changes in the
estimated impacts against the concentration index of the
model input that was ignored and then compared these
across both models to explore the possible patterns
between the extent of inequality of model inputs and the
variations in estimated impacts on overall health and
health inequality.
Results
The results of the base case and scenario analyses are
summarized in Table 2 and plotted in Figures 1 and 2.
These base case estimates indicate that compared with
no intervention, e-cigarette was estimated to increase
overall health (iNHB = 80,782 QALYs) but increase
health inequality (iEDE – iNHB = 210,780 QALYs),
whereas the alcohol Next Registration strategy was esti-
mated to increase overall health (iNHB = 4336 QALYs)
and reduce inequality (iEDE – iNHB = 444 QALYs;
Table 2).
(a) How Influential Is Failing to Consider
Socioeconomic Differences?
Ignoring socioeconomic differences in all model inputs.
Compared with the base case, ignoring socioeconomic
differences in all model inputs reduced the amount by
which the interventions were predicted to increase overall
health (smoking model: 2272 QALYs, 20.34%; alcohol
model: 2253 QALYs, 25.83%; Table 2); e-cigarette was
predicted to have no effect on inequality, and the alcohol
Next Registration strategy was predicted to increase
inequality (Table 2; Figure 1).
Ignoring socioeconomic difference in one model input.
Compared with the base case, in the smoking model,
ignoring the socioeconomic difference in smoking preva-
lence resulted in the greatest increase in the estimated
overall health impact (4902 QALYs, 6.07% greater than
the total in base case), while ignoring the difference in
intervention effectiveness resulted in the greatest reduc-
tion (23,546 QALYs, 24.39%; Table 2). In the alcohol
model, ignoring the socioeconomic difference in mean
alcohol consumption resulted in the greatest increase in
the estimated overall health impact (756 QALYs,
17.44%), while ignoring the difference in drinking preva-
lence resulted in the greatest reduction (2389 QALYs,
28.97%; Table 2).
In the smoking model, ignoring the socioeconomic dif-
ferences in health opportunity costs, smoking prevalence,
and risk of smoking-related diseases increased the extent
by which the intervention was estimated to increase
inequality, whereas ignoring socioeconomic differences
in baseline QALE, mortality risks, HRQoL, effective-
ness, and uptake reduced this extent (with removal of the
socioeconomic difference in uptake making e-cigarette
inequality reducing) compared with the base case (Figure
1a). In the alcohol model, ignoring the socioeconomic
differences in average weekly consumption, peak day
consumption, screening coverage, likelihood of screening
positive, and the health opportunity costs increased the
extent by which the intervention was estimated to reduce
inequality, while ignoring the socioeconomic differences
in abstention from drinking, alcohol-related diseases,
and mortality rates reduced it (with removal of the socio-
economic difference in morbidity making the strategy
inequality increasing; Figure 1b).
(b) Which Modifiable Intervention
Characteristics Represent the Most Value?
Leveling up the effectiveness and uptake of the smoking
cessation intervention increased the estimated overall health
impact by 7448 QALYs (9.22%) and 28,875 QALYs
(35.74%), respectively, and reduced the extent by which it
was predicted to increase inequality, with leveling up uptake
making e-cigarette inequality reducing as compared with
the base case (Table 2; Figure 2a).
In the alcohol model, increasing coverage of the Next
Registration strategy to the age-sex specific maximum
level increased the estimated improvement in overall
health by 480 QALYs (11.07%) and increased the extent
by which it was estimated to reduce inequality, and
increasing the coverage to population maximum level
increased the estimated improvement in overall health by
13,556 QALYs (312.64%) and reduced health inequality
to a much greater extent (Table 2; Figure 2b).
(c) How Generalizable Are Conclusions
between Settings?
Results per 100,000 adults for each setting are presented
in Figure 3. In the smoking model, using local level
612 Medical Decision Making 40(5)













Smoking model (e-cigarette v. no intervention)
Base case 80,782 2 70,002 210,780 Increase inequality
(a) Ignoring all differences 80,510 2272 (20.34%) 80,510 10,508 (15.01%) 0 Smaller increase
(b) Ignoring difference in: Baseline QALE 80,782 0 (0%) 80,781 10,779 (15.40%) 21 Smaller increase
Health opportunity costs 80,782 0 (0%) 69,019 2983 (21.40%) 211,763 Larger increase
Smoking prevalence 85,683 4902 (6.07%) 69,454 2548 (20.78%) 216,229 Larger increase
Mortality 79,543 21239 (21.53%) 70,261 259 (0.37%) 29282 Smaller increase
Smoking-related diseases 82,418 1636 (2.03%) 70,853 851 (1.22%) 211,564 Larger increase
HRQoL 80,628 2153 (20.19%) 70,053 51 (0.07%) 210,575 Smaller increase
Effectiveness 77,236 23546 (24.39%) 69,942 260 (20.09%) 27294 Smaller increase
Uptake 80,436 2345 (20.43%) 81,463 11,461 (16.37%) 1027 Inequality-reducing
(c) Leveling up to the best in: Effectiveness 88,229 7448 (9.22%) 79,929 9927 (14.18%) 28300 Smaller increase
Uptake 109,656 28,875 (35.74%) 111,057 41,055 (58.65%) 1400 Inequality-reducing
Alcohol model (‘‘Next Registration’’ v. no intervention)
Base case 4336 — 4780 — 444 Reduce inequality
(a) Ignoring all differences 4083 2253 (25.83%) 3580 21199 (225.08%) 2503 Increases inequality
(b) Ignoring difference in: Baseline QALE 4336 0 (0%) 4336 2444 (29.29%) 0 Smaller reduction
Health opportunity costs 4336 0 (0%) 4989 209 (+4.37%) 652 Larger reduction
Abstention 3947 2389 (28.97%) 4125 2655 (213.7%) 178 Smaller reduction
Mortality 4530 194 (+4.47%) 4565 2215 (24.5%) 35 Smaller reduction
Alcohol-related diseases 4856 519 (+11.97%) 4645 2135 (22.82%) 2211 Inequality-increasing
Average weekly consumption 5092 756 (+17.44%) 6253 1474 (+30.84%) 1162 Larger reduction
Peak day consumption 4724 388 (+8.95%) 5421 642 (+13.43%) 698 Larger reduction
Screening coverage 4493 157 (+3.62%) 5492 713 (+14.92%) 999 Larger reduction
Screening positive (risky level) 4803 466 (+10.75%) 5512 732 (+15.31%) 709 Larger reduction
(c) Leveling up to the best in: Screening rates (age-sex max) 4817 480 (+11.07%) 6213 1433 (+29.98%) 1397 Larger reduction
Screening rates (global max) 17,893 13,556 (+312.64%) 22,141 17,361 (+363.2%) 4248 Larger reduction




evidence, e-cigarette was estimated to improve overall
health in England, York, and Sheffield with different
magnitudes of impacts (Figure 3a); it was estimated to
increase inequality in Sheffield and England but reduce
inequality in York (Figure 3a). The alcohol Next
Registration strategy was estimated to increase overall
health and reduce inequality in England and both local
authorities, but the greatest increase in overall health
was in Liverpool, and the greatest reduction in health
inequality was in Trafford (Figure 3b).
Figure 2 Health equity impact plane showing scenario analysis results when leveling up to the best. (a) Smoking model. (b)
Alcohol model. Compared with the base case, if the location of the result in the scenario analysis moves upward on the y-axis,
the model estimates more health improvement; if the location moves toward the right side on the x-axis, the model estimates less
inequality. For example, in the smoking model, the result of leveling up uptake moves upward and to the right, which indicates
more health improvement and less inequality compared with the base case. The location of ‘‘uptake’’ is in the northeast
quadrant, indicating the intervention is estimated to reduce inequality.
Figure 1 Health equity impact plane showing scenario analysis results in which socioeconomic differences are ignored. (a) Smoking
model. (b) Alcohol model. In the health equity plane, the y-axis is the increase in population health, and the x-axis is the reduction
in health inequality. Interventions that improve overall health fall in the north of the plane. Interventions that reduce inequality fall
in the east of the plane. E-cigarette was estimated to increase overall health and increase inequality, so it is located in the northwest
quadrant. ‘‘Next Registration’’ was estimated to increase overall health and reduce inequality, so it is located in the northeast
quadrant. Compared with the base case, if the location of the result in the scenario analysis moves upward on the y-axis, the model
estimates more health improvement; if the location moves toward the right side on the x-axis, the model estimates less inequality.
For example, in the smoking model, the result of ignoring the socioeconomic difference in effectiveness moves downward and to
the right, which indicates less health improvement and less inequality compared with the base case.
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(d) How Generalizable Are the Results between
Models and Disease Areas?
The concentration index of each model input and the
amount by which ignoring it alters the estimated intervention
impacts on overall health and health inequality is plotted in
Supplementary Figure S7 and Figure 4, respectively. In both
models, there was no clear pattern relating inequality of the
model input to how it alters the estimated impact on overall
health (Supplementary Figure S7). In the smoking model,
Figure 3 Equity impact plane showing the overall health and health inequality for local authority analysis. (a) Smoking model.
(b) Alcohol model. Compared with the base case, if the location of the result in the scenario analysis moves upward on the
y-axis, the model estimates more health improvement; if the location moves toward the right side on the x-axis, the model
estimates less inequality. For example, in the smoking model, the result for Sheffield moves upward and to the left, which
indicates more health improvement and more inequality, compared with the result for England.
Figure 4 Impact on health inequality versus concentration index where socioeconomic differences are ignored. (a) Smoking
model. (b) Alcohol model.
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there was a positive correlation between the concentration
index and the impact of ignoring socioeconomic differences
in that input on the estimated health inequality impact as
compared with the base case (Figure 4a). Ignoring the socio-
economic differences in model inputs that are more concen-
trated on the less deprived (positive concentration index
values) increases the amount by which the intervention is
estimated to reduce inequality, while ignoring the socioeco-
nomic differences in model inputs concentrated on the more
deprived results (negative concentration index values)
decreases it. However, this pattern was not clearly observed
in the alcohol model (Figure 4b).
Discussion
Evidence on how the impacts of policies vary across pop-
ulation groups is vital to inform decisions that rest on
consideration of impacts on overall health and health
inequality. By interrogating 2 different DCEA models
that feature opposite effects on inequality, we demon-
strated how the evidence for socioeconomic differences
in policy impact could be evaluated within a DCEA
framework, which represents a form of stratified CEA.
Good understanding of how and when accounting for
socioeconomic differences between groups affects the
assessment of intervention impacts on overall health and
health inequality could advise researchers as to whether
it is possible to simplify the DCEA process and inform
decision makers where DCEA would add most value.
First, we found that failing to consider socioeconomic
differences would affect the estimated policy impacts to
a different degree between the 2 models. It has a more
minor influence on the estimated overall health impact
in the smoking model and a greater influence in the non-
linear alcohol model (smoking model: 20.34% alcohol
model: 25.83%). As anticipated, it greatly affected the
estimated impact on health inequality, influencing not
only the magnitude but also the direction of effect (smok-
ing: increase inequality to no effect; alcohol: reduce
inequality to increase inequality). Ignoring socioeconomic
differences in just one input can have a substantial effect
on the results, but we found no clear relationship that
might predict which model inputs are most influential.
Second, leveling up modifiable intervention character-
istics to the highest level achieved in any subgroup would
improve the estimated health inequality impact to the
direction that favors the interventions. It also increases
the estimated overall health impact, so it would not
impose a trade-off between improvement in overall
health and reduction in inequality. Socioeconomic varia-
tion in smoking cessation uptake appears a more
valuable target for modification than socioeconomic var-
iation in effectiveness. This could inform decision makers
where to focus efforts to make policies benefit popula-
tion groups more fairly. It should be noted that such
efforts usually attract additional costs, and further analy-
sis would be needed to explore whether the benefits are
worthwhile.
Third, the magnitude of impacts on overall health and
health inequality at one local authority was different
compared with that at another local authority or the
nation as a whole. In the smoking model, the direction of
the impact was also different (e-cigarette was estimated
to reduce inequality in York but to increase inequality
measured across England and Sheffield). The inconsis-
tency in the policy impacts between settings is likely to be
driven by the different deprivation structures of the
populations and the local level socioeconomic differ-
ences. This suggests that caution should be taken when
generalizing recommendations of interventions from the
national level to local authorities and between local
authorities differing in deprivation structure of the popu-
lation and other model inputs. Prioritization and local
level decision making could be better supported by con-
ducting and reporting analyses that reflect differences rel-
evant to the local context.
The conclusions that can be drawn from this study are
limited as they are based on only 2 models. Although
both decision models have been used to support real
resource allocation decisions in the UK, the base case
results may omit potential socioeconomic differences in
inputs where evidence was not available. For example, if
disease-related events require more resource use for treat-
ment or impose a greater quality-of-life decrement in
more deprived groups, the socioeconomic differences in
health care costs and health-related quality of life would
be underestimated. In view of this, sensitivity analyses of
more DCEA models can be combined with the results
from our analysis to further our understanding of how
influential it is to consider socioeconomic differences in
different types of model input on the estimated policy
impacts. We have not considered alternative interven-
tions or designs of the interventions (e.g., extra efforts on
targeting disadvantaged groups), which would be
expected to have alternative impacts on inequalities, but
there is scope for the use of DCEA and other methods to
help inform how best to design interventions to impact
on inequality. In addition, the evidence on socioeco-
nomic differences in model inputs is associated with
uncertainty. The smoking model incorporated this uncer-
tainty, which could be analyzed with a probabilistic sen-
sitivity analysis, to provide credible intervals around
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estimated policy impacts. However, the computing time
for the individual simulation alcohol model was already
high and did not allow for probabilistic sensitivity analy-
sis. Consequently, we did not compare the influence of
uncertainty across the 2 models.
The results presented in this study indicate that between-
group differences in patterns of disease, intervention effi-
cacy, and intervention use can combine and interact in a
complex manner and produce results that are difficult to
predict. Thus, a formal analysis of inequality impact, such
as that provided by a full DCEA, can be beneficial in guid-
ing resource allocation decisions. In practice, the decision
on whether to conduct a DCEA or some other form of stra-
tified analysis may be informed by qualitative approaches,
similar to those used in the integrated health technology
assessment (HTA) process.30 A number of other methods
have been proposed in the literature for including health
inequality concerns in economic evaluation, for example,
the extended CEA,31 but these methods would rely on the
same evidence on socioeconomic differences used here5 and
do not use inequality indices to explicitly analyze trade-offs
between improving health and reducing health inequality.
Although we have seen in this study that additional work is
needed to conduct the DCEA and the approach would
increase complexity and introduce uncertainty, the applica-
tions of DCEA have shown that it is feasible to implement
within a typical HTA process, and the skills required lie
within the capabilities of analysts currently conducting
CEA.4 The trade-offs between health improvement and
inequality reduction, informed by a full DCEA, would
assist decision makers to clarify and quantify the nature of
their inequality concerns and provide better ways of com-
municating findings to wider audiences.4
Conclusions
By conducting 2 case studies, one assessing smoking ces-
sation intervention and the other assessing alcohol screen-
ing and brief intervention, we found that conclusions
about their impact on health inequality are strongly influ-
enced by socioeconomic differences in model inputs, but
not in an easy way to predict. This affirms the potential
value for increasing the extent of formal and quantitative
analysis of health inequality impacts to inform resource
allocation decisions. Our study also suggests the need for
better consideration of the diversity in deprivation struc-
ture, epidemiology, and access to services across settings.
Note
The work was undertaken at the Centre for Health Economics,
University of York, and the Sheffield Alcohol Research Group,
Health Economics and Decision Science, ScHARR, University
of Sheffield; the work was presented at Society for Social





Supplementary material for this article is available on the
Medical Decision Making Web site at http://journals.sagepub
.com/home/mdm.
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